These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10097145)

  • 41. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds.
    Kreitman RJ; Batra JK; Seetharam S; Chaudhary VK; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1993; 4(2):112-20. PubMed ID: 7873642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3.
    Benhar I; Pastan I
    J Biol Chem; 1995 Oct; 270(40):23373-80. PubMed ID: 7559495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice.
    Benhar I; Reiter Y; Pai LH; Pastan I
    Int J Cancer; 1995 Jul; 62(3):351-5. PubMed ID: 7628878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Frösch B; Waibel R; Schenker T; Stahel RA
    Br J Cancer; 1994 Jan; 69(1):32-9. PubMed ID: 7506925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics.
    Machesky NJ; Rusnak JM; Moore EH; Dorsey CB; Ward LA
    Toxicon; 2019 Sep; 167():152-161. PubMed ID: 31207351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant hybrid toxin with dual enzymatic activities. Potential use in preparing highly effective immunotoxins.
    Li BY; Ramakrishnan S
    J Biol Chem; 1994 Jan; 269(4):2652-8. PubMed ID: 8300596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
    Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
    Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes.
    Banker DE; Pastan I; Gottesman MM; Herschman HR
    J Cell Physiol; 1989 Apr; 139(1):51-7. PubMed ID: 2496133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions.
    Reiter Y; Brinkmann U; Kreitman RJ; Jung SH; Lee B; Pastan I
    Biochemistry; 1994 May; 33(18):5451-9. PubMed ID: 7910034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Brinkmann U; Reiter Y; Jung SH; Lee B; Pastan I
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7538-42. PubMed ID: 8356052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies.
    Mansfield E; Pastan I; FitzGerald DJ
    Bioconjug Chem; 1996; 7(5):557-63. PubMed ID: 8889017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
    Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
    Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display.
    Beers R; Chowdhury P; Bigner D; Pastan I
    Clin Cancer Res; 2000 Jul; 6(7):2835-43. PubMed ID: 10914732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.
    Kaplan G; Lee F; Onda M; Kolyvas E; Bhardwaj G; Baker D; Pastan I
    Toxins (Basel); 2016 Jul; 8(8):. PubMed ID: 27463727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of 3'-azido-3'-deoxythymidine inhibition of ricin and Pseudomonas exotoxin A toxicity in CHO and Vero cells.
    Wellner RB; Pless DD; Thompson WL
    J Cell Physiol; 1994 Jun; 159(3):495-505. PubMed ID: 8188764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redirecting Pseudomonas exotoxin.
    FitzGerald D; Pastan I
    Semin Cell Biol; 1991 Feb; 2(1):31-7. PubMed ID: 1954341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins.
    Brinkmann U; Brinkmann E; Pastan I
    Mol Med; 1995 Jan; 1(2):206-16. PubMed ID: 8529099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections.
    Brinkmann U; Buchner J; Pastan I
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3075-9. PubMed ID: 1557415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma.
    Kreitman RJ; Puri RK; Pastan I
    Cancer Res; 1995 Aug; 55(15):3357-63. PubMed ID: 7614471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Site-specific conjugation to interleukin 4 containing mutated cysteine residues produces interleukin 4-toxin conjugates with improved binding and activity.
    Kreitman RJ; Puri RK; Leland P; Lee B; Pastan I
    Biochemistry; 1994 Sep; 33(38):11637-44. PubMed ID: 7918378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.